These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7865190)

  • 1. Two-compartment model of cholesterol kinetics for establishment of treatment strategy of LDL apheresis in nephrotic hypercholesterolemia.
    Yashiro M; Muso E; Matsushima M; Nagura R; Sawanishi K; Sasayama S
    Blood Purif; 1994; 12(6):317-26. PubMed ID: 7865190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
    Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits.
    Yamamoto T; Yamashita T
    Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Takemura T; Miki S; Kuwahara T; Takamitsu Y; Tsubakihara Y;
    Nephron; 2001 Dec; 89(4):408-15. PubMed ID: 11721158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A; Harada-Shiba M; Endo M; Kusakabe N; Tanioka T; Kato H; Shoji T
    Atherosclerosis; 2006 May; 186(1):126-31. PubMed ID: 16043185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
    Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
    Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
    Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
    Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
    Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL Apheresis: an effective and safe treatment for refractory hypercholesterolemia.
    Hudgins LC; Gordon BR; Parker TS; Saal SD; Levine DM; Rubin AL
    Cardiovasc Drug Rev; 2002; 20(4):271-80. PubMed ID: 12481200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
    Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
    J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of LDL-apheresis on the long-term prognosis of hypercholesterolemic patients with coronary artery bypass grafts: a multicenter study].
    Kito Y; Takahashi J; Endo M; Agishi T; Kitamura S; Matsuda H; Fujiwara T; Dohi T; Ito T; Kawashima Y
    Kyobu Geka; 1993 May; 46(5):399-404. PubMed ID: 8492490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LDL cholesterol apheresis by adsorption to dextran sulfate].
    Grunewald RW; Ditschuneit HH; Klein J; König W; Grunewald JM; Franz HE
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):194-6. PubMed ID: 1422078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome.
    Miyata H; Uno K; Ono T; Yashiro M; Fukatsu A; Kita T; Kimura T; Muso E
    Ther Apher Dial; 2012 Apr; 16(2):189-94. PubMed ID: 22458400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.
    Masin V; Blaha M; Stransky P; Blaha V; Cermanova M; Maly R; Zajic J
    Transfus Apher Sci; 2007 Feb; 36(1):39-45. PubMed ID: 17292673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome.
    Kuribayashi-Okuma E; Shibata S; Arai S; Ota T; Watanabe S; Hisaki H; Okazaki T; Toda T; Uchida S
    Ther Apher Dial; 2016 Apr; 20(2):174-82. PubMed ID: 26771065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.